The FLF joins forces with the LLS to bring hope to those living with follicular lymphoma
The FLF joins forces with The Leukemia & Lymphoma Society to bring hope to those living with follicular lymphoma. The partnership marks a significant milestone in accelerating leading edge research.
Exciting insights about follicular lymphoma at 17-ICML
This article presents key insights from the conference, shedding light on exciting developments in the field. The knowledge and insights we gained left us inspired and energised.
Highlights from our satellite symposium
At the 17th International Conference on Malignant Lymphoma (17-ICML), the FLF hosted their own symposium: “What Will it Take to Cure FL?”. Read more to find out the key takeaways and highlights from the symposium.
Mid-year update – Making strides towards a cure
In just the last six months, we have made tangible progress in advancing research, raising awareness, and working closely with patients.
Dr Mitchell Smith on Future Directions in FL
Dr Mitchell Smith on Future Directions in FL Dr Mitchell Smith, CMO at the FLF, shares his insights in what the future holds for follicular lymphoma research. In his article, he outlines the key questions in follicular lymphoma, and lays out which areas of research look to be most promising in leading us to better […]
Celebrating the success of our first webinar
On May 18th, the FLF hosted our very first webinar called “An Overview of Follicular Lymphoma: What You Need to Know.”
FLF formalises presence in Israel
We’re thrilled to share a big step forward in our fight against follicular lymphoma. In April of this year, our founder, Nicola Mendelsohn, officially opened the new branch of the Follicular Lymphoma Foundation in Israel.
FLF hosts first International Summit in Tel Aviv
The Follicular Lymphoma Foundation (FLF) proudly hosted its first international FL Summit, titled “Joining Forces to Cure Follicular Lymphoma,” in Tel Aviv, Israel. The summit, held in January 2023, exceeded all expectations and marked a major milestone for the FLF. The summit brought together a diverse group of lymphoma experts, scientists, researchers, and representatives from […]
ASH Annual Meeting 2022 – Research and insight summary
ASH Annual Meeting 2022 – summary and key take-outs By Dr Zoe Drymoussi During the 9-12th December 2022, the FLF team attended, in person, for the biggest events of the year in the world of haematology – the American Society of Hematology (ASH) annual meeting. More than 25,000 delegates, showcasing 3000+ abstracts, took over the […]
Looking back over the last 25 years for FL – the Rituximab era
Looking back over the last 25 years for FL – the Rituximab era By Dr Mitchell Smith, Chief Medical Officer A recent re-publication marking 25 years since the seminal 1998 Journal of Clinical Oncology paper (1) upon which Rituximab was approved for relapsed/refractory follicular or low-grade lymphoma (1997 by U.S. FDA, and 1998 by European […]